Beckman Coulter Diagnostics, founded in 1935 and based in the United States, operates within the business services sector, specifically focusing on research and development, manufacturing, and wholesale in the electrical and electronic manufacturing industries. The company specializes in diagnostic solutions and laboratory automation, as evidenced by its publication on the DxA 5000 system. This document outlines a clinical laboratory observational impact study conducted at the Hospital Universitario de Poniente in Spain, which analyzed the efficiency of the pre-analytical workflow before and after the installation of the Total Laboratory Automation (TLA) system. The study reported significant reductions in turnaround times (TAT) for various laboratory processes, highlighting improvements in operational efficiency and staff safety through decreased manual handling of samples. The results indicated a marked enhancement in performance metrics, showcasing the company's commitment to advancing diagnostic capabilities and laboratory efficiency. Beckman Coulter Diagnostics employs over 10,000 individuals and reported substantial revenue, reflecting its prominent role in the diagnostic and laboratory automation market.